Assenagon Asset Management S.A. Clear Point Neuro, Inc. Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$9.82 - $16.49 $500,181 - $839,918	50,935 New	50,935 $528,000
Q2 2022 Jul 27, 2022	SELL	$7.09 - $13.65 $855,685 - $1.65 Million	-120,689 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$7.8 - $11.6 $641,635 - $954,227	82,261 Added 214.07%	120,689 $1.26 Million
Q4 2021 Feb 01, 2022	BUY	$11.08 - $18.86 $425,782 - $724,752	38,428 New	38,428 $431,000
Q3 2021 Oct 19, 2021	SELL	$16.58 - $22.25 $800,067 - $1.07 Million	-48,255 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$17.23 - $22.77 $831,433 - $1.1 Million	48,255 New	48,255 $921,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.